Implication of inhaled nitric oxide for the treatment of critically ill COVID ‐19 patients with pulmonary hypertension

ConclusionsInhaled nitric oxide treatment was beneficial in reducing and stabilizing the PASP and might also reduce the risk of right heart failure in COVID ‐19 with pulmonary hypertension.

Source: ESC Heart Failure - November 17, 2020 Category: Cardiology Authors: Wen ‐Xia Feng, Yang Yang, Junmin Wen, Ying‐Xia Liu, Lei Liu, Cheng Feng Tags: Short Communication Source Type: research